| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,545 | 19,110 | 16,401 | 21,364 | | Cost of Revenue | 11,743 | 12,049 | 10,715 | 13,023 | | | Gross Profit | 6,802 | 7,061 | 5,686 | 8,341 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,870 | 5,934 | 6,566 | 7,103 | | Non Recurring |
-
|
-
|
-
| 14,267 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 932 | 1,127 | (880) | (13,029) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (20) | 26 | (7) | (78) | | Earnings Before Interest And Taxes | (84) | 1,153 | (887) | (13,107) | | Interest Expense | (650) | 338 | 312 | 322 | | Income Before Tax | 566 | 815 | (1,199) | (13,428) | | Income Tax Expense | 295 | 475 | (609) | 486 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 271 | 340 | (590) | (13,914) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 271 | 340 | (590) | (13,914) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $271 | $340 | ($590) | ($13,914) |
|
0.26% Nasdaq 
0.1971 (8.61%) 
Income Statement
